Rheumatoid Arthritis Clinical Trial
Official title:
Observational Study for the Assessment of Quality of Life Related to Health in Users of the Spa of Fitero (Navarra).
Verified date | May 2019 |
Source | University of Castilla-La Mancha |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Hypothesis: The spa therapy treatment could improve health-related quality of life (HRQOL) in
subjects with knee and/or hip osteoarthritis, and patients with rheumatoid arthritis.
Main objective: Analyze if HRQOL in patients with knee and/or hip osteoarthritis, and
patients with rheumatoid arthritis is modified by spa therapy treatment in the spa of Fitero
(Spain).
Design: Prospective observational study Participants: Fitero's spa users aged between 45-80
years old, diagnosed with knee and/or hip osteoarthritis, and also with rheumatoid arthritis.
At least 40 patients of each type will be included in the study. Participants must be
receiving a treatment of at least ten days.
Main Variable: The scores obtained in the Euroqol5Dimensions-5Levels questionnaire (EQ-5D-5L)
(for all subjects), the Western Ontario MacMaster Universities Osteoarthritis Index (WOMAC)
questionnaire, for subjects with knee and/or hip osteoarthritis, and the Health Assessment
Questionnaire (HAQ), for subjects with rheumatoid arthritis.
Other variables: sociodemographic, anthropometric, clinics, and related with spa treatment.
Follow-up duration: 9 months.
Status | Active, not recruiting |
Enrollment | 80 |
Est. completion date | December 1, 2019 |
Est. primary completion date | March 1, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 45 Years to 80 Years |
Eligibility |
Inclusion Criteria: - diagnosed arthrosis of knee or hip and/or rheumatoid arthrosis - balneotherapy treatment of at least 10 days. - physically and mentally able to complete questionnaires Exclusion Criteria: - have followed a balneotherapy treatment in the six previous month |
Country | Name | City | State |
---|---|---|---|
Spain | Universidad de Castilla-La Mancha | Toledo |
Lead Sponsor | Collaborator |
---|---|
University of Castilla-La Mancha |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | HAQ (Health Assessment Questionnaire)-Disability of rheumatic patients | Health Assessment Questionnaire (HAQ) assays the disability of rheumatic patients to carry out daily life activities. The questionary consists on 20 daily life questions, grouped in 8 areas, each one containing two or three questions related to daily life activities. Each question is scored from 0-3. 0 means "done without difficulties" (no disability), 3 score is "impossible to do" (completely disabled). The average of all responses is done. Average scores from 0-1 represent "mild to moderate difficulty", 1-2 means "moderate to severe disability", 3-2 indicates "severe to very severe disability". | From 1st March 2019 to 1st December 2019 | |
Primary | WOMAC | Western Ontario MacMaster Universities Osteoarthritis Index (WOMAC) | From 1st March 2019 to 1st December 2019 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04226131 -
MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics
|
N/A | |
Completed |
NCT04171414 -
A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT02833350 -
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
|
Phase 2 | |
Completed |
NCT04255134 -
Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
|
Phase 4 | |
Recruiting |
NCT05615246 -
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
|
||
Completed |
NCT03248518 -
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
|
N/A | |
Completed |
NCT03514355 -
MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms
|
N/A | |
Recruiting |
NCT06005220 -
SBD121, a Synbiotic Medical Food for RA Management
|
N/A | |
Recruiting |
NCT05451615 -
Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT05054920 -
Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT02037737 -
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
|
N/A | |
Recruiting |
NCT04079374 -
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
|
Phase 3 | |
Completed |
NCT02504268 -
Effects of Abatacept in Patients With Early Rheumatoid Arthritis
|
Phase 3 | |
Recruiting |
NCT05496855 -
Remote Care in People With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Recruiting |
NCT06031415 -
Study of GS-0272 in Participants With Rheumatoid Arthritis
|
Phase 1 | |
Recruiting |
NCT06103773 -
A Study of Single and Multiple Oral Doses of TollB-001
|
Phase 1 | |
Completed |
NCT05999266 -
The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
|
||
Recruiting |
NCT05302934 -
Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
|
||
Recruiting |
NCT04169100 -
Novel Form of Acquired Long QT Syndrome
|
Phase 4 |